[1]
Abdoli Shadbad, M. et al. 2024. hsa-miR-34a-5p enhances temozolomide anti-tumoral effects on glioblastoma: in-silico and in-vitro study. EXCLI Journal. 23, (Mar. 2024), 384–400. DOI:https://doi.org/10.17179/excli2023-6404.